Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system

J Pediatr. 2015 Jan;166(1):144-50. doi: 10.1016/j.jpeds.2014.09.017. Epub 2014 Oct 14.

Abstract

Objective: To characterize heparin-induced thrombocytopenia (HIT) at a single pediatric center including the prevalence and the accuracy of the 4Ts scoring system as a predictor of HIT.

Study design: In this retrospective cohort study, we identified 155 consecutive patients <21 years old with sufficient data for 4Ts scoring. The 4Ts scoring system is a validated pretest tool in adults that predicts the likelihood of HIT using clinical features. Hospital-wide exposure to unfractionated and low molecular weight heparin was determined by querying the hospital pharmacy database.

Results: The majority of patients with suspected HIT (61.2%) were on surgical services. Prediction of HIT risk using initial 4Ts scoring found 3 (2%) had high risk 4Ts scores, 114 (73%) had intermediate risk 4Ts scores, and the remaining 38 (25%) had low risk 4Ts scores. HIT was confirmed in 0/38 patients with low risk 4Ts scores, 2/114 patients with intermediate-risk 4Ts scores, and all 3 patients with high-risk 4Ts scores presented with HIT with thrombosis. Of 12 positive HIT screening tests, results were falsely positive in 66.6% of patients with intermediate risk 4Ts scores and 100% of patients with low risk 4Ts scores. The prevalence of HIT was 0.058% and HIT with thrombosis was 0.046% in pediatric patients on unfractionated heparin.

Conclusions: The prevalence of HIT appears significantly lower in pediatric patients compared with adults. Application of the 4Ts system as a pretest tool may reduce laboratory evaluation for HIT in heparin-exposed children with low risk 4Ts scores, decreasing unnecessary further testing, intervention, and cost.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Boston
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Fibrinolytic Agents / adverse effects*
  • Heparin / adverse effects*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Prevalence
  • Retrospective Studies
  • Risk Factors
  • Sensitivity and Specificity
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / epidemiology
  • Thrombosis / chemically induced*
  • Young Adult

Substances

  • Fibrinolytic Agents
  • Heparin